<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Freiburg_References skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Freiburg/References</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="flex-container1"><DIV class="flex-item2"><DIV class="dropdown"><DIV class="dropdown-content"><A href="https://2017.igem.org/Team:Freiburg/Introduction">Overview</A><A href="https://2017.igem.org/Team:Freiburg/Motivation">Motivation</A><A href="https://2017.igem.org/Team:Freiburg/CAR">CAR T Cells</A><A href="https://2017.igem.org/Team:Freiburg/Tumor_microenvironment">Tumor Microenvironment</A><A href="https://2017.igem.org/Team:Freiburg/Design">AND Gate</A><A href="https://2017.igem.org/Team:Freiburg/Outlook">Outlook</A><A href="https://2017.igem.org/Team:Freiburg/Achievements">Achievements</A><A href="https://2017.igem.org/Team:Freiburg/References">References</A></DIV></DIV></DIV><DIV class="flex-item3"><DIV class="dropdown"><DIV class="dropdown-content"><A href="https://2017.igem.org/Team:Freiburg/Team">Members</A><A href="https://2017.igem.org/Team:Freiburg/Attributions">Attributions</A><A href="https://2017.igem.org/Team:Freiburg/Sponsors">Partners</A><A href="https://2017.igem.org/Team:Freiburg/Contact">Contact</A></DIV></DIV></DIV><DIV class="flex-item4"><DIV class="dropdown"><DIV class="dropdown-content"><A href="https://2017.igem.org/Team:Freiburg/Results">Main Project</A><A href="https://2017.igem.org/Team:Freiburg/Model">Modeling</A><A href="https://2017.igem.org/Team:Freiburg/Applied_Design">Applied Design</A><A href="https://2017.igem.org/Team:Freiburg/Demonstrate">Proof of Concept</A><A href="https://2017.igem.org/Team:Freiburg/Basic_Part">BioBricks Basic Part</A><A href="https://2017.igem.org/Team:Freiburg/Improve">BioBrick Improvement</A><A href="https://2017.igem.org/Team:Freiburg/InterLab">Interlab Study</A></DIV></DIV></DIV><DIV class="flex-item5"><DIV class="dropdown"><DIV class="dropdown-content"><A href="https://2017.igem.org/Team:Freiburg/Safety">Safety</A><A href="https://2017.igem.org/Team:Freiburg/Cloning">Cloning</A><A href="https://2017.igem.org/Team:Freiburg/Lab_Knockout"><I>HIF1A</I> Knockdown</A><A href="https://2017.igem.org/Team:Freiburg/Cell_culture">Cell Culture</A><A href="https://2017.igem.org/Team:Freiburg/Notebook">Lab Book</A></DIV></DIV></DIV><DIV class="flex-item6"><DIV class="dropdown"><DIV class="dropdown-content"><A href="https://2017.igem.org/Team:Freiburg/HP/Silver">Human Practice</A><A href="https://2017.igem.org/Team:Freiburg/HP/Gold_Integrated">Integrated Human Practice</A><A href="https://2017.igem.org/Team:Freiburg/Collaborations">Collaborations</A></DIV></DIV></DIV></DIV><DIV class="container"><DIV class="row"><DIV class="col-md-12 text-center"><DIV class="flex-container"><H1 align="center">References</H1><DIV class="item"><P><SPAN style="font-variant: small-caps;">Ashour, M. B. A., Gee, S. J. &amp; Hammock, B. D.</SPAN> Use of a 96-well microplate reader for measuring routine enzyme activities.<I> Anal. Biochem.</I><B>166</B>, 353–360 (1987).

</P><P><SPAN style="font-variant: small-caps">Ausländer, D. <I>et al.</I></SPAN>. A synthetic multifunctional mammalian pH sensor and CO<SUB>2</SUB> transgene-control device. <I>Mol. Cell</I><B>55</B>, 397–408 (2014).

</P><P><SPAN style="font-variant: small-caps;">Badran, A. H. &amp; Liu, D. R.</SPAN> Development of potent in vivo mutagenesis plasmids with broad mutational spectra. <I>Nat. Commun.</I><B>6</B>, 8425 (2015).


</P><P><SPAN style="font-variant: small-caps;">Bittinger, M. A. <I>et al</I></SPAN> Activation of cAMP Response Element-Mediated Gene Expression by Regulated Nuclear Transport of TORC Proteins. <I>Current Biology</I>, <B>Vol. 14</B>, 2156–2161 (2004).


</P><P><SPAN style="font-variant: small-caps;">Bondanza, A. <I>et al.</I></SPAN> Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. <I>Memory</I><B>107</B>, 1828–1836 (2006).

</P><P><SPAN style="font-variant: small-caps;">Brophy, J. A. N. &amp; Voigt, C. A.</SPAN> Principles of genetic circuit design. <I>Nat. Methods</I><B>11</B>, 508–520 (2014).


</P><P><SPAN style="font-variant: small-caps;">Chen, T. <I>et al</I></SPAN> Modeling gene expression with differential equations. <I>Pac Symp Biocomput.</I> (1999).

</P><P><SPAN style="font-variant: small-caps;">Cherkassky, L. <I>et al.</I></SPAN> Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition. <I>J. Clin. Invest.</I><B>126</B>, 3130–3144 (2016).

</P><P><SPAN style="font-variant: small-caps;">Damaghi, M., Wojtkowiak, J. W. &amp; Gillies, R. J.</SPAN> pH sensing and regulation in cancer. <I>Front. Physiol.</I><B>4 DEC</B>, 1–10 (2013).

</P><P><SPAN style="font-variant: small-caps;">Dangl, J. L. &amp; Lanier, L. L.</SPAN> Founding father of FACS: Professor Leonard A. Herzenberg (1931-2013). <I>Proc. Natl. Acad. Sci.</I><B>110</B>, 20848–20849 (2013).


</P><P><SPAN style="font-variant: small-caps;">Dawson, R. M. C. <I>et al.</I></SPAN> Data for Biochemical Research. <I>Oxford Science Publ.</I>, <B>3rd</B> edition, (1986).</P><P><SPAN style="font-variant: small-caps;">Dey, D., Evans, G.R.D.</SPAN> Suicide Gene Therapy by Herpes Simplex Virus-1 Thymidine Kinase (HSV-TK). <I>InTech</I>, <B>DOI: 10.5772/18544</B> (2011).

</P><P><SPAN style="font-variant: small-caps;">Doench, J. G. <I>et al.</I></SPAN> Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. <I>Nat. Biotechnol.</I><B>34</B>, 184–191 (2016).

</P><P><SPAN style="font-variant: small-caps;">Epstein, A. C. R. <I>et al.</I></SPAN> C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. <I>Cell</I><B>107</B>, 43–54 (2001).

</P><P><SPAN style="font-variant: small-caps;">Fellmann, C. <I>et al.</I></SPAN> An optimized microRNA backbone for effective single-copy RNAi. <I>Cell Rep.</I><B>5</B>, 1704–1713 (2013).

</P><P><SPAN style="font-variant: small-caps;">Fesnak, A. D., June, C. H. &amp; Levine, B. L.</SPAN> Engineered T cells: the promise and challenges of cancer immunotherapy. <I>Nat. Rev. Cancer</I><B>16</B>, 566–81 (2016).

</P><P><SPAN style="font-variant: small-caps;">Fillat, C., Carrió, M., Cascante, A. &amp; Sangro, B.</SPAN> Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. <I>Curr Gene There</I><B>3</B>, 13–26 (2003).

</P><P><SPAN style="font-variant: small-caps;">Finley, S. D. &amp; Popel, A. S. </SPAN>Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: Systems biology predictions. <I>J. Natl. Cancer Inst.</I><B>105</B>, 802–811 (2013).

</P><P><SPAN style="font-variant: small-caps;">Fire, A. <I>et al.</I></SPAN> Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. <I>Nature</I><B>391</B>, 806–811 (1998).

</P><P><SPAN style="font-variant: small-caps;">Fischer, U. <I>et al.</I></SPAN> Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. <I>Oncogene</I><B>24</B>, 1231–1243 (2005).

</P><P><SPAN style="font-variant: small-caps;">Gibson, H. M. <I>et al.</I></SPAN> Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter. <I>J. Immunol.</I><B>179</B>, 3831–3840 (2007).

</P><P><SPAN style="font-variant: small-caps;">Gilham, D. E., Debets, R., Pule, M., Hawkins, R. E. &amp; Abken, H.</SPAN> CAR-T cells and solid tumors: Tuning T cells to challenge an inveterate foe. <I>Trends Mol. Med.</I><B>18</B>, 377–384 (2012).

</P><P><SPAN style="font-variant: small-caps;">Hager, S., Frame, F. M., Collins, A. T., Burns, J. E. &amp; Maitland, N. J.</SPAN> An Internal Polyadenylation Signal Substantially Increases Expression Levels of Lentivirus-Delivered Transgenes but Has the Potential to Reduce Viral Titer in a Promoter-Dependent Manner. <I>Hum. Gene Ther.</I><B>19</B>, 840–850 (2008).

</P><P><SPAN style="font-variant: small-caps;">Hanahan, D. &amp; Coussens, L. M.</SPAN> Accessories to the Crime : Functions of Cells Recruited to the Tumor Microenvironment. <I>Cancer Cell</I><B>21</B>, 309–322 (2012).


</P><P><SPAN style="font-variant: small-caps;">Hartmann, J., Schüßler‐Lenz, M., Bondanza, A. &amp; Buchholz, C. J.</SPAN> Clinical development of CAR T cells—challenges and opportunities in translating innovative treatment concepts. <I>EMBO Mol. Med.</I> e201607485 (2017). <B>doi:10.15252/emmm.201607485</B>.

</P><P><SPAN style="font-variant: small-caps;">Houot, R., Schultz, L. M., Marabelle, A. &amp; Kohrt, H.</SPAN> T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition. <I>Cancer Immunol. Res.</I><B>3</B>, 1115–1122 (2015).

</P><P><SPAN style="font-variant: small-caps;">Ingalls, B.</SPAN> Mathematical Modeling in Systems Biology: An Introduction. 1–396 (2012).

</P><P><SPAN style="font-variant: small-caps;">Jackson, R. E. &amp; Burrone, J.</SPAN> Visualizing Presynaptic Calcium Dynamics and Vesicle Fusion with a Single Genetically Encoded Reporter at Individual Synapses. <B>8</B>, 1–12 (2016).

</P><P><SPAN style="font-variant: small-caps;">Jackson, H. J., Rafiq, S. &amp; Brentjens, R. J.</SPAN> Driving CAR T-cells forward. <I>Nat. Rev. Clin. Oncol.</I><B>13</B>, 370–83 (2016).



</P><P><SPAN style="font-variant: small-caps;">Kato, Y. <I>et al.</I></SPAN> Acidic extracellular microenvironment and cancer. <I>Cancer Cell Int.</I><B>13</B>, 89 (2013).

</P><P><SPAN style="font-variant: small-caps;">Liu, W. <I>et al.</I></SPAN> Expression and characterization of a soluble VEGF receptor 2 protein. <I>Cell Biosci.</I><B>4</B>, 14 (2014).

</P><P><SPAN style="font-variant: small-caps;">Lomnitz, J. G. &amp; Savageau, M. A.</SPAN> Rapid Discrimination Among Putative Mechanistic Models of Biochemical Systems. <I>Sci. Rep.</I><B>6</B>, 32375 (2016).


</P><P><SPAN style="font-variant: small-caps;">Magee, M. S., Snook, A.</SPAN> Challenges to Chimeric Antigen Receptor (CAR)-T Cell Therapy for Cancer. <I>Discov Med</I> <B>18</B>(100):265-271, (2014).


</P><P><SPAN style="font-variant: small-caps;">Mahindhoratep, S. <I>et al.</I></SPAN> NF-kB related transgene expression in mouse tibial cranial muscle after pDNA injection followed or not by electrotransfer. <I>Biochim. Biophys. Acta - Gen. Subj.</I><B>1840</B>, 3257–3263 (2014).

</P><P><SPAN style="font-variant: small-caps;">Mahnke, Y. D., Brodie, T. M., Sallusto, F., Roederer, M. &amp; Lugli</SPAN>, E. The who’s who of T-cell differentiation: Human memory T-cell subsets. <I>Eur. J. Immunol.</I><B>43</B>, 2797–2809 (2013).

</P><P><SPAN style="font-variant: small-caps;">Masters, J. R. &amp; Stacey, G. N.</SPAN> Changing medium and passaging cell lines. <I>Nat. Protoc.</I><B>2</B>, 2276–2284 (2007).

</P><P><SPAN style="font-variant: small-caps;">McKeown, S. R.</SPAN> Defining normoxia, physoxia and hypoxia in tumours - Implications for treatment response. <I>Br. J. Radiol.</I><B>87</B>, 1–12 (2014).

</P><P><SPAN style="font-variant: small-caps;">Mech, L. D. A. </SPAN> Gray Wolf (Canis lupus) Delivers Live Prey to a Pup. <I>Can. Field-Naturalist</I><B>128</B>, 189–190 (2014).

</P><P><SPAN style="font-variant: small-caps;">Michel, M. <I>et al.</I></SPAN> TT‐seq captures enhancer landscapes immediately after T‐cell stimulation. <I>Mol. Syst. Biol.</I><B>13</B>, 920 (2017).

</P><P><SPAN style="font-variant: small-caps;">Miettinen, M., Rikala, M.-S., Rysz, J., Lasota, J. &amp; Wang, Z.-F.</SPAN> Study of 262 Vascular Endothelial and 1640. <I>Am. J. Surg. Pathol.</I><B>36</B>, 629–639 (2012).


</P><P><SPAN style="font-variant: small-caps;">Miller, M. J., Wei, S. H., Cahalan, M. D. &amp; Parker, I.</SPAN> Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. <I>Proc. Natl. Acad. Sci. U. S. A.</I><B>100</B>, 2604–2609 (2003).

</P><P><SPAN style="font-variant: small-caps;">Minami, T. <I>et al.</I></SPAN> The Calcineurin-NFAT-Angiopoietin 2 signaling axis in lung endothelium is critical for the establishment of lung metastases. <I>NIH Public Access.</I><B>4</B>, 709–723 (2013).

</P><P><SPAN style="font-variant: small-caps;">Mittal, K., Ebos, J. &amp; Rini, B.</SPAN> Angiogenesis and the tumor microenvironment: Vascular endothelial growth factor and beyond. <I>Semin. Oncol.</I><B>41</B>, 235–251 (2014).

</P><P><SPAN style="font-variant: small-caps;">Morgan, R. A. <I>et al.</I></SPAN> Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ErbB2. <I>Mol. Ther.</I><B>18</B>, 843–851 (2010).

</P><P><SPAN style="font-variant: small-caps;">Moroz, E. <I>et al.</I></SPAN> Real-time imaging of HIF-1a stabilization and degredation. <I>PLoS One</I><B>4</B>, (2009).


</P><P><SPAN style="font-variant: small-caps;">Narendranath, N. V, Thomas, K. C. &amp; Ingledew, W. M.</SPAN> Effects of acetic acid and lactic acid on the growth of Saccharomyces cerevisiae in a minimal medium. <I>J. Ind. Microbiol. Biotechnol.</I><B>26</B>, 171–177 (2001).

</P><P><SPAN style="font-variant: small-caps;">Neelapu, S. S. <I>et al.</I></SPAN> Axicabtagene Ciloleucel ( Axi ‐ Cel ; Kte ‐ C19 ) in Patients With Refractory Aggressive Non ‐ Hodgkin Lymphomas ( Nhl ): Primary Results of the Pivotal Trial Zuma ‐ 1 Immunotherapy From Malignant. <I>Hematol. Oncol.</I><B>35</B>, 28–28 (2017).

</P><P><SPAN style="font-variant: small-caps;">Nguyen, L. K. <I>et al.</I></SPAN> A dynamic model of the hypoxia-inducible factor 1a (HIF-1a) network. <I>J. Cell Sci.</I><B>128</B>, 422–422 (2012).

</P><P><SPAN style="font-variant: small-caps;">Parkinson, M. J. &amp; Lilley, D. M.</SPAN> The junction-resolving enzyme T7 endonuclease I: quaternary structure and interaction with DNA. <I>J. Mol. Biol.</I><B>270</B>, 169–78 (1997).

</P><P><SPAN style="font-variant: small-caps;">Patel, A., Sant, S.</SPAN> Hypoxic Tumor Microenvironment: Opportunities to Develop Targeted Therapies. <B>25</B>, 368–379 (2015).

</P><P><SPAN style="font-variant: small-caps;">Pescador, N. <I>et al.</I></SPAN> Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. <I>Biochem. J.</I><B>390</B>, 189–197 (2005).

</P><P><SPAN style="font-variant: small-caps;">Punj, V. <I>et al.</I></SPAN> Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. <I>Oncogene</I><B>23</B>, 2367–78 (2004).


</P><P><SPAN style="font-variant: small-caps;">Quail, D. F. &amp; Joyce, J. A.</SPAN> Microenvironmental regulation of tumor progression and metastasis. <I>Nat. Med.</I><B>19</B>, 1423–1437 (2013).

</P><P><SPAN style="font-variant: small-caps;">Ran, F. A. <I>et al.</I></SPAN> Genome engineering using the CRISPR-Cas9 system. <I>Nat. Protoc.</I><B>8</B>, 2281–2308 (2013).

</P><P><SPAN style="font-variant: small-caps;">Riedel E., Janiak C.</SPAN> Anorganische Chemie, <B>6.</B> Auflage, p321 (de Gruyter, 2004).

</P><P><SPAN style="font-variant: small-caps;">Sadelain, M., Brentjens, R. &amp; Rivière, I.</SPAN> The basic principles of chimeric antigen receptor design. <I>Cancer Discov.</I><B>3</B>, 388–398 (2013).


</P><P><SPAN style="font-variant: small-caps;">Sanjana, N. E., Shalem, O. &amp; Zhang, F.</SPAN> Improved vectors and genome-wide libraries for CRISPR screening. <I>Nat. Methods</I><B>11</B>, 783–784 (2014).

</P><P><SPAN style="font-variant: small-caps;">Schödel, J., Oikonomopoulos, S. &amp; Mole, D. R.</SPAN> High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq Methods Cell culture. <B>117</B>, 207–218 (2011).

</P><P><SPAN style="font-variant: small-caps;">Singer, B. D., King, L. S. &amp; D’Alessio, F. R.</SPAN> Regulatory T cells as immunotherapy. <I>Front. Immunol.</I><B>5</B>, 1–10 (2014).


</P><P><SPAN style="font-variant: small-caps;">Singh, H. <I>et al</I></SPAN> A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19. <I>NIH Public Access</I>. 257(1): 181–190. <B>doi:10.1111/imr.12137</B> (2015).

</P><P><SPAN style="font-variant: small-caps;">Stemmer, M., Thumberger, T., Del Sol Keyer, M., Wittbrodt, J. &amp; Mateo, J. L.</SPAN> CCTop: An intuitive, flexible and reliable CRISPR/Cas9 target prediction tool. <I>PLoS One</I><B>10</B>, 1–11 (2015).

</P><P><SPAN style="font-variant: small-caps;">Tian, L., Bae, Y. H.</SPAN> Cancer Nanomedicines Targeting Tumor Extracellular pH. <I>NIH Public Access.</I><B>42</B>, 115–125 (2009).

</P><P><SPAN style="font-variant: small-caps;">Thomas, P. &amp; Smart, T. G.</SPAN> HEK293 cell line: A vehicle for the expression of recombinant proteins. <I>J. Pharmacol. Toxicol. Methods</I><B>51</B>, 187–200 (2005).

</P><P><SPAN style="font-variant: small-caps;">Tomicic, M. T., Thust, R. &amp; Kaina, B.</SPAN> Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation. <I>Oncogene</I><B>21</B>, 2141–2153 (2002).


</P><P><SPAN style="font-variant: small-caps;">Verzeletti, S. <I>et al.</I></SPAN> Herpes Simplex Virus Thymidine Kinase Gene Transfer for Controlled Graft-versus-Host Disease and Graft-versus- Leukemia : Clinical Follow-up and Improved New Vectors <B>2251</B>, 2243–2251 (1998).

</P><P><SPAN style="font-variant: small-caps;">Voron, T. <I>et al.</I></SPAN> VEGF-A modulates expression of inhibitory checkpoints on CD8 + T cells in tumors. <I>J. Exp. Med.</I><B>212</B>, 139–148 (2015).

</P><P><SPAN style="font-variant: small-caps;">Wang, L. <I>et al.</I></SPAN> SynBioLGDB: a resource for experimentally validated logic gates in synthetic biology. <I>Sci. Rep.</I><B>5</B>, 8090 (2015).


</P><P><SPAN style="font-variant: small-caps;">Whiteside, T.L.</SPAN> The tumor microenvironment and its role in promoting tumor growth. <I>NIH Public Access</I> <B>70</B>, 646–656 (2008).


</P><P><SPAN style="font-variant: small-caps;">Wu, D. &amp; Yotnda, P.</SPAN> Induction and Testing of Hypoxia in Cell Culture. <I>J. Vis. Exp.</I> 4–7 (2011). <B>doi:10.3791/2899</B>.

</P><P><SPAN style="font-variant: small-caps;">Yang, Y., Jacoby, E. &amp; Fry, T. J.</SPAN> Challenges and opportunities of allogeneic donor-derived CAR T cells. <I>Curr. Opin. Hematol.</I><B>22</B>, 509–15 (2015).

</P><P><SPAN style="font-variant: small-caps;">Zhang, C., Liu, J., Zhong, J. F. &amp; Zhang, X.</SPAN> Engineering CAR-T cells. <I>Biomark. Res.</I><B>5</B>, 22 (2017).

</P><P><SPAN style="font-variant: small-caps;">Ziello, J. E., Jovin, I. S. &amp; Huang, Y.</SPAN> Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. <I>Yale J. Biol. Med.</I><B>80</B>, 51–60 (2007).











</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>